| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,060 | 2,200 | 19:04 |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 12.02. | Biodexa Pharmaceuticals PLC: Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status | CARDIFF, UK / ACCESS Newswire / February 12, 2025 / Biodexa Pharmaceuticals PLC. (NASDAQ:BDRX), a clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment... ► Artikel lesen | |
| 10.02. | Biodexa stock soars 76% on FDA Fast Track status for eRapa | ||
| 10.02. | Biodexa Pharmaceuticals PLC: Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis | February 10, 2025 Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Underscores unmet need for a therapeutic alternative with the potential to delay or prevent... ► Artikel lesen | |
| 10.02. | Biodexa Pharmaceuticals Plc - 6-K, Report of foreign issuer | ||
| 22.01. | Biodexa Pharmaceuticals Names Gary Shangold Chief Medical Officer |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Granite REIT declares CAD 0.2833 dividend | ||
| 14.02. | GRANITE REAL ESTATE INVESTMENT TRUST - 6-K, Report of foreign issuer | ||
| 05.02. | Granite Real Estate Investment Trust: Granite REIT completes $300-million debenture offering | ||
| 31.01. | Dividendenbekanntmachungen (31.01.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AES CORPORATION US00130H1059 0,1759 USD 0,1693 EUR AGNC INVESTMENT CORP US00123Q1040 0,12 USD 0,1155 EUR AGREE REALTY CORPORATION US0084921008 0... ► Artikel lesen | |
| 31.01. | Granite Real Estate Investment Trust: Granite REIT prices debentures of $300-million offering |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 19.12.24 | LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance | Achieved total revenue of RMB 371.9 million, reflecting a growth of 36.2% YoY
Achieved gross profit of RMB 307.3 million, a growth of 39.1% YoY
Gross margin... ► Artikel lesen | |
| 13.12.24 | LakeShore Biopharma Co., Ltd: LakeShore Biopharma Provides Update on Ongoing Criminal Investigation Involving Former Chairman in China | BEIJING, Dec. 12, 2024 (GLOBE NEWSWIRE) -- LakeShore Biopharma Co., Ltd. (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a leading global biopharmaceutical company focused on the innovation... ► Artikel lesen | |
| 12.12.24 | LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer | ||
| 01.11.24 | LakeShore Biopharma Co., Ltd. - 6-K, Report of foreign issuer | ||
| 29.10.24 | LakeShore Biopharma erfüllt wieder Nasdaq-Anforderungen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 23.01. | Sify Technologies to invest $5bn in Indian AI data center expansion | ||
| 17.01. | Sify Technologies Earnings Report: Q3 Overview | ||
| 17.01. | Sify Technologies reports Q3 results | ||
| 17.01. | Sify Technologies Limited: Sify reports Consolidated Financial Results for Q3 FY 2024-25 | Revenues of INR 10,491 Million. EBITDA of INR 1,914 Million. Loss for the period INR 258 Million. CHENNAI, India, Jan. 17, 2025 (GLOBE NEWSWIRE) -- EARNING CALLS DETAILS January 17, 2025 | 8:30... ► Artikel lesen | |
| 14.01. | SIFY TECHNOLOGIES LTD - 6-K, Report of foreign issuer |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.01. | Streamline Health Solutions, Inc.: Streamline Health Announces Fourth CommunityWorks RevID Contract With Kentucky-Based Health System | ||
| 15.01. | Streamline Health Solutions, Inc.: Streamline Health Announces New eValuator Contract with Deaconess Health System | ||
| 20.12.24 | STREAMLINE HEALTH SOLUTIONS INC. - 10-Q, Quarterly Report | ||
| 18.12.24 | Streamline Health Solutions, Inc.: Streamline Health Expands Presence In Texas with 400-Bed Health System for RevID | ||
| 16.12.24 | Streamline Health GAAP EPS of -$0.61 misses by $0.16, revenue of $4.42M misses by $0.89M |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Teekay projects $14,300 breakeven supporting strong free cash flow in volatile tanker market | ||
| Mi | Teekay Corporation Profit Drops In Q4 | ||
| Mi | Teekay GAAP EPS of $0.19, revenue of $256.57M | ||
| Mi | Teekay Corporation Ltd. Reports Fourth Quarter and Annual 2024 Results | ||
| Mi | TEEKAY CORP LTD - 6-K, Report of foreign issuer |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC ADR | 3,610 | -5,00 % |
| GRANITE REAL ESTATE INVESTMENT TRUST UTS | 44,835 | -5,75 % |
| LAKESHORE BIOPHARMA CO LTD | 2,120 | +1,92 % |
| SIFY TECHNOLOGIES LIMITED ADR | 4,560 | 0,00 % |
| STREAMLINE HEALTH SOLUTIONS INC | 3,650 | +2,53 % |
| TEEKAY CORPORATION LTD | 6,400 | 0,00 % |
